Skip to main content
Clinical Trials/ISRCTN99747069
ISRCTN99747069
Completed
未知

A comparative study of virtual reality versus in vivo exposure in the cognitive behavior treatment of social phobia

Social Sciences and Humanities Research Council (Canada)0 sites59 target enrollmentSeptember 23, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Social phobia
Sponsor
Social Sciences and Humanities Research Council (Canada)
Enrollment
59
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/27979818/ (added 18/12/2020)

Registry
who.int
Start Date
September 23, 2010
End Date
August 18, 2011
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Social Sciences and Humanities Research Council (Canada)

Eligibility Criteria

Inclusion Criteria

  • 1\. Ambulatory men and women
  • 2\. At least 18 years old and at most 65 years old
  • 3\. French speaking
  • 4\. Receiving a principal diagnosis of social anxiety disorder (SAD) according to DSM\-IV\-TR?s diagnostic criteria. Assessed at a psychiatric interview, standardized with the Structured Clinical Interview for DSM (SCID)
  • 5\. Suffering from SAD since at least two years
  • 6\. If currently taking medication for SAD, pharmacotherapy must be stabilized (same type and dosage) for at least six months and the social phobia remained stable and uncured (i.e., still meeting diagnostic criteria despite take the medication)
  • Note that there is no perfect solution to the problem of medication since most severe cases already receive Selective Serotonin Reuptake Inhibitor (SSRI) from their doctors when they seek psychological treatments (thus, recruiting non\-medicated participants would threaten the feasibility of the study and could lead to the selection of less severe cases) and stopping medication would induce other methodological problems (e.g., withdrawal symptoms, artificial peak of severity at pre\-treatment, ethical issues).

Exclusion Criteria

  • 1\. Currently suffering from a severe organic disease, dementia, mental retardation, schizophrenia, amnesia, psychosis or bipolar disorder
  • 2\. The SAD being secondary to any DSM\-IV Axis\-III diagnosis
  • 3\. Receiving any form of concurrent psychotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials